{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/622b8f5080a3a00013890f23/673159441f785cb57144b97c?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Monday, November 11, 2024","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/622b8f5080a3a00013890f23/1731287277814-ac8e6dbf-da8a-4e4e-a180-993276b58e40.jpeg?height=200","description":"<ul><li>General Catalyst’s HATco signs a definitive agreement to purchase Akron, OH-based Summa Health.&nbsp;The Food and Drug Administration plans to remove a common—but ineffective—decongestant ingredient from the market.&nbsp;And, more young people are landing in the emergency department for consuming too much caffeine. We’ll get that story—and more—coming up on today’s episode of the Gist Healthcare</li></ul><p><br></p>","author_name":"Gist Healthcare Daily"}